Perioperative intensive care for cardiac surgery patients

doi:10.16139/j.1007-9610.2023.05.03

Abstract

Abstract:

The rapid development of perioperative intensive care in cardiac surgery has greatly improved the prognosis for patients undergoing major cardiovascular surgery. In the field of hemodynamics, besides traditional methods, such as a variety of arterial catheters and central venous catheter, thermodilution and echocardiography have gradually becoming routines in hemodynamic monitoring, but their clinical values require further investigation. At the same time, optimizing micro-circulation, in order to meet the demand of oxygen and metabolism, is the goal of hemodynamic resuscitation. The management of V-A extracorporeal membrane oxygenation (ECMO) in the perioperative period of cardiac surgery depends on persistent hemodynamic monitoring. Volume management, vasoactive drugs, inotropes and vasodilators are still keys in pharmacological management. In addition, many mechanical circulatory assist devices have brought more treatments and hope for end-stage heart failure and severe cardiopulmonary dysfunction.

Key words: Intensive care, Cardiac surgery, Hemodynamics, Mechanical circulatory

CLC Number:

LIU Hua, LUO Minghao, TU Guowei, LUO Zhe. Perioperative intensive care for cardiac surgery patients[J]. Journal of Surgery Concepts & Practice, 2023, 28(05): 409-414.

References 34

[1]	TEBOUL J L, SAUGEL B, CECCONI M, et al. Less invasive hemodynamic monitoring in critically ill patients[J]. Intensive Care Med, 2016, 42(9):1350-1359. doi: 10.1007/s00134-016-4375-7 URL
[2]	MONNET X, MARIK P E, TEBOUL J L. Prediction of fluid responsiveness: an update[J]. Ann Intensive Care, 2016, 6(1):111. doi: 10.1186/s13613-016-0216-7 pmid: 27858374
[3]	SAUGEL B, KOUZ K, SCHEEREN T W L, et al. Cardiac output estimation using pulse wave analysis-physiology, algorithms, and technologies: a narrative review[J]. Br J Anaesth, 2021, 126(1):67-76. doi: 10.1016/j.bja.2020.09.049 pmid: 33246581
[4]	DE BACKER D, AISSAOUI N, CECCONI M, et al. How can assessing hemodynamics help to assess volume status?[J]. Intensive Care Med, 2022, 48(10):1482-1494. doi: 10.1007/s00134-022-06808-9 pmid: 35945344
[5]	SAUGEL B, MALBRAIN M L, PEREL A. Hemodynamic monitoring in the era of evidence-based medicine[J]. Crit Care, 2016, 20(1):401. doi: 10.1186/s13054-016-1534-8 URL
[6]	CECCONI M, DE BACKER D, ANTONELLI M, et al. Consensus on circulatory shock and hemodynamic monitoring. Task Force of the European Society of Intensive Care Medicine[J]. Intensive Care Med, 2014, 40(12):1795-1815. doi: 10.1007/s00134-014-3525-z pmid: 25392034
[7]	JUHL-OLSEN P, SMITH S H, GREJS A M, et al. Automated echocardiography for measuring and tracking cardiac output after cardiac surgery: a validation study[J]. J Clin Monit Comput, 2020, 34(5):913-922. doi: 10.1007/s10877-019-00413-w
[8]	FLICK M, BERGHOLZ A, SIERZPUTOWSKI P, et al. What is new in hemodynamic monitoring and management?[J]. J Clin Monit Comput, 2022, 36(2):305-313. doi: 10.1007/s10877-022-00848-8 pmid: 35394584
[9]	BRUNO R R, WOLLBORN J, FENGLER K, et al. Direct assessment of microcirculation in shock: a randomized-controlled multicenter study[J]. Intensive Care Med, 2023, 49(6):645-655. doi: 10.1007/s00134-023-07098-5 pmid: 37278760
[10]	DURANTEAU J, DE BACKER D, DONADELLO K, et al. The future of intensive care: the study of the microcirculation will help to guide our therapies[J]. Crit Care, 2023, 27(1):190. doi: 10.1186/s13054-023-04474-x
[11]	MERDJI H, LEVY B, JUNG C, et al. Microcirculatory dysfunction in cardiogenic shock[J]. Ann Intensive Care, 2023, 13(1):38. doi: 10.1186/s13613-023-01130-z pmid: 37148451
[12]	LUO J C, ZHANG J D, ZHAO Q Y, et al. Infrared thermography-based body-surface thermal inhomogeneity monitoring to assess the severity of hypoperfusion in critically ill patients[J]. Shock, 2022, 58(5):366-373. doi: 10.1097/SHK.0000000000001998 URL
[13]	SU Y, LIU K, ZHENG J L, et al. Hemodynamic monitoring in patients with venoarterial extracorporeal membrane oxygenation[J]. Ann Transl Med, 2020, 8(12):792. doi: 10.21037/atm.2020.03.186 pmid: 32647717
[14]	TSANGARIS A, ALEXY T, KALRA R, et al. Overview of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support for the management of cardiogenic shock[J]. Front Cardiovasc Med, 2021, 8:686558. doi: 10.3389/fcvm.2021.686558 URL
[15]	VIGNON P, REPESSE X, BEGOT E, et al. Comparison of echocardiographic indices used to predict fluid responsiveness in ventilated patients[J]. Am J Respir Crit Care Med, 2017, 195:1022-1032. doi: 10.1164/rccm.201604-0844OC URL
[16]	LUO J C, SU Y, DONG L L, et al. Trendelenburg maneuver predicts fluid responsiveness in patients on veno-arterial extracorporeal membrane oxygenation[J]. Ann Intensive Care, 2021, 11(1):16. doi: 10.1186/s13613-021-00811-x
[17]	WELKER C C, MIELKE J A R, RAMAKRISHNA H, et al. Levosimendan and low cardiac output after cardiac surgery: analysis of trial data[J]. J Cardiothorac Vasc Anesth, 2023, 37(7):1294-1297. doi: 10.1053/j.jvca.2023.03.011 URL
[18]	LANDONI G, LOMIVOROTOV V V, ALVARO G, et al. Levosimendan for hemodynamic support after cardiac surgery[J]. N Engl J Med, 2017, 376(21):2021-2031. doi: 10.1056/NEJMoa1616325 URL
[19]	STEPHENS R S, WHITMAN G J R. Postoperative critical care of the adult cardiac surgical patient. Part Ⅰ: routine postoperative care[J]. Crit Care Med, 2015, 43:1477-1497. doi: 10.1097/CCM.0000000000001059 URL
[20]	NAGPAL A D, SINGAL R K, ARORA R C, et al. Temporary mechanical circulatory support in cardiac critical care: a state of the art review and algorithm for device selection[J]. Can J Cardiol, 2017, 33:110-118. doi: S0828-282X(16)31050-9 pmid: 28024549
[21]	KANTROWITZ A, TJΦNNELAND S, FREED P S, et al. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock[J]. JAMA, 1968, 203(2):113-118. doi: 10.1001/jama.1968.03140020041011 URL
[22]	DARRAH W C, SHARPE M D, GUIRAUDON G M, et al. Intraaortic balloon counterpulsation improves right ventricular failure resulting from pressure overload[J]. Ann Thorac Surg, 1997, 64:1718-1723. pmid: 9436561
[23]	HEUTS S, LORUSSO R, MAURO M, et al. Sheathless versus sheathed intra-aortic balloon pump implantation in patients undergoing cardiac surgery[J]. Am J Cardiol, 2023, 189:86-92. doi: 10.1016/j.amjcard.2022.11.033 URL
[24]	COCHRAN R P, STARKEY T D, PANOS A L, et al. Ambulatory intraaortic balloon pump use as bridge to heart transplant[J]. Ann Thorac Surg, 2002, 74:746-751. pmid: 12238834
[25]	BROWN M A, SHEIKH F H, AHMED S, et al. Intra-aortic balloon pump as a bridge to durable left ventricular assist device[J]. J Am Heart Assoc, 2021, 10(15):E019376. doi: 10.1161/JAHA.120.019376 URL
[26]	THIELE H, ZEYMER U, THELEMANN N, et al. Intraaortic balloon pump in cardiogenic shock complicating acute myocardial infarction: long-term 6-year outcome of the randomized IABP-SHOCK Ⅱ Trial[J]. Circulation, 2019, 139(3):395-403. doi: 10.1161/CIRCULATIONAHA.118.038201 URL
[27]	ANDERSON M B, GOLDSTEIN J, MILANO C, et al. Benefits of a novel percutaneous ventricular assist device for right heart failure: the prospective RECOVER RIGHT study of the Impella RP device[J]. J Heart Lung Transplant, 2015, 34(12):1549-1560. doi: 10.1016/j.healun.2015.08.018 URL
[28]	PAPOLOS A I, BARNETT C F, TULI A, et al. Impella management for the cardiac intensivist[J]. ASAIO, 2022, 68(6):753-758. doi: 10.1097/MAT.0000000000001680 URL
[29]	HILL J D, O’BRIEN T G, MURRAY J J, et al. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung[J]. N Engl J Med, 1972, 286:629-634. doi: 10.1056/NEJM197203232861204 URL
[30]	WELKER C C, HUANG J, BOSWELL M R, et al. Left ventricular decompression in VA-ECMO: analysis of techniques and outcomes[J]. J cardiothorac Vasc Anesth, 2022, 36(11):4192-4197. doi: 10.1053/j.jvca.2022.07.024 pmid: 35965232
[31]	SCHRAGE B, BECHER P M, BERNHARDT A, et al. Left ventricular unloading is associated with lower morta-lity in patients with cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation: results from an international, multicenter cohort study[J]. Circulation, 2020, 142(22):2095-2106. doi: 10.1161/CIRCULATIONAHA.120.048792 URL
[32]	MONLINA E J, SHAH P, KIERNAN M S, et al. The so-ciety of thoracic surgeons intermacs 2020 annual report[J]. Ann Thorac Surg, 2021, 111:778-802. doi: 10.1016/j.athoracsur.2020.12.038 URL
[33]	MEHRA M R, GOLDSTEIN D J, CLEVELAND J C, et al. Five-year outcomes in patients with fully magnetically levitated vs axial-flow left ventricular assist devices in the MOMENTUM 3 randomized trial[J]. JAMA, 2022, 328(12):1233-1242. doi: 10.1001/jama.2022.16197 URL
[34]	VARSHNEY A S, DEFILIPPIS E M, COWGER J A, et al. Trends and outcomes of left ventricular assist device therapy[J]. JACC, 2022, 79(11):1092-1107.